Trials / Completed
CompletedNCT00743873
Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation
PRP Treatment for Medial Retinaculum Tear - Randomized-Double-Blind-Placebo Control Trail
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Meir Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
To check the influence of injected platelet-rich plasma (PRP) on the healing of medial retinaculum and the redaction in recurrent dislocation of the patella.
Detailed description
Autologous platelet-rich matrices may aid in the healing of ligaments \& tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Plasma Rich in Growth Factors (PRGF) | US guided IM injection 3-6mg |
| DRUG | placebo | injection of 6 cc of saline into injured area |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-02-01
- Completion
- 2009-03-01
- First posted
- 2008-08-29
- Last updated
- 2011-07-12
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00743873. Inclusion in this directory is not an endorsement.